Transplantation of ACE2 – Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia
Orginal Article
[키워드] ACE2
ACE2 negative
addition
adverse effect
adverse effects
Beijing
C-reactive protein
caused
cell population
cell transplantation
change
China
clinical outcomes
control group
coronavirus
COVID-19
COVID-19 infection
discharged
effective
enrolled
function recovery
functional
gene expression profile
IL-10
Immune cell
immune function
immunomodulation
immunomodulatory
IMPROVE
indicated
Inflammatory
injection
intravenous
mesenchymal stem cell
Mesenchymal stem cells
MSC
MSCs
NK cell
novel coronavirus disease
outbreak
outcome
Patient
patients with COVID-19
peripheral lymphocyte
Placebo
Pneumonia
Preventing
Pulmonary function
Regulatory
Safe
Seven
Severe COVID-19 pneumonia
Severe patient
shown
significantly
STEM
Symptom
T cells
the cytokine storm
the patient
TMPRSS2
TNF-α
transplantation
Treatment
treatment group
were assessed
with COVID-19
Wuhan, China
[DOI] 10.14336/AD.2020.0228 PMC 바로가기 [Article Type] Orginal Article
[DOI] 10.14336/AD.2020.0228 PMC 바로가기 [Article Type] Orginal Article